This is a research study to learn if a new experimental drug when given with standard of care is safe and effective as a treatment for men with metastatic hormone-sensitive prostate cancer (mHSPC). The drugs that are part of this study are Docetaxel and Radium-223.
Thank you for your interest, but this study is not currently enrolling.
Young Whang
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Prostate)
Urinary and Bladder
Men's Health
22-1269
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
